Novavax to Participate in September Investor Conferences

GAITHERSBURG, Md., Sept. 2, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that company management will participate in the following upcoming investor conferences:

• 2026 Cantor Global Healthcare Conference, New York
  
  Fireside chat on Wednesday, September 9, 2026, at 9:45 a.m. EDT

• Citi's 2026 BioPharma Back to School Conference, New York
  
  Fireside chat on Thursday, September 10, 2026, at 10:00 a.m. EDT

A live webcast of the fireside chats will be available on the "Events & Presentations" page of the Company's website at ir.novavax.com. A replay of each webcast will be available for 30 days following the presentation.

About Novavax

Novavax, Inc. (Nasdaq: NVAX) tackles some of the world's most pressing health challenges with its scientific expertise in vaccines and its proven technology platform, including its Matrix-M^® adjuvant and protein-based nanoparticles. The Company's corporate growth strategy is designed to deliver value via three key strategic pillars: partnering its technology, capital-efficient research and development (R&D) innovation and a lean and efficient operating model. This includes maximizing impact through partnerships for its marketed products (Nuvaxovid™, R21/Matrix-M™), Matrix technology and R&D assets. Please visit novavax.com and LinkedIn for more information. 

Contacts:

Investors

Naina Zaman 

844-668-2829 

ir@novavax.com 

Media 

Yvonne Sprow 

844-264-8571 

media@novavax.com 

SOURCE Novavax, Inc.